drugset / Trial / NCT01783561

Early Versus Routine Caffeine Administration in Extremely Preterm Neonates

NCT01783561

Phase 4 Completed 21 enrolled Sharp HealthCare
RandomizedParallel-groupTriple-blindPrevention

Summary

Premature infants are at risk of having pauses in breathing, or apneas, due to their immaturity. Premature infants are routinely given caffeine, a respiratory stimulant, on the first day of life to prevent apneas. However, if they continue to have apneas, they may require a breathing tube to be placed in the trachea. There are risks to having a breathing tube, so it would be beneficial to avoid it if possible. If caffeine is given earlier, it may decrease the need for a breathing tube. Some studies also suggest that caffeine may also improve heart function which may prevent low blood pressure if given early.

Timeline

Start
2013-10
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Caffeine Small molecule 20 mg/kg Intravenous

Indications

No indication recorded.